logo
logo

Nashville Biosciences Appoints Dan Benetz As Chief Financial Officer and Geoff Nilsen As Vice President and Head of Omics

Jul 23, 2024about 1 year ago

Position

Head of Omics

Company

NashBio

Geoff Nilsen
NashvilleBiotechnology

Description

Nashville Biosciences, LLC (NashBio) announces the appointment of Dan Benetz as its chief financial officer (CFO) and Geoff Nilsen as vice president and head of omics. The company has also made internal promotions for Curt Allen to vice president of sales and Wacey Richards to vice president of engineering.

Company Information

Company

NashBio

Location

Nashville, Tennessee, United States

About

NashBio, a wholly owned subsidiary of Vanderbilt University Medical Center, was created to harness the medical center's extensive genomic and bioinformatics resources for drug and diagnostics discovery and development. Leveraging Vanderbilt University Innovation™, NashBio serves as a commercial interface between outside companies and the formidable research capabilities housed within Vanderbilt University Medical Center, including BioVU®, one of the world’s most comprehensive genetic databases linked to de-identified medical records with years of longitudinal clinical data. This unique asset is one of the largest and highest quality of its kind, providing an unprecedented opportunity to guide R&D activity in biotech, pharma, diagnostics, medical devices and other life sciences applications.

Related People

Sign in to view contact details

Sign in to view contact details

Sign in to view contact details

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months